FDA Makes 2nd Attempt At Virtual MDUFA Public Meeting
Executive Summary
For the second time in the past few months the US agency has rescheduled a webcast of a public meeting meant to start MDUFA V user-fee negotiations.
You may also be interested in...
Hahn Offers Upbeat User-Fee Prediction At AdvaMed Conference
The US FDA commish praised the medical device community's work in response to the COVID-19 pandemic and predicted that communication developed with industry during the crisis may ease upcoming MDUFA negotiations.
Spurred On By HHS Policy Shift, AdvaMed Chief Wants LDT Reform In User-Fee Negotiations
The medical device advocacy group plans to include laboratory developed test reform in their upcoming user-fee negotiations with the US FDA.
Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel
In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.